hrp0082p2-d2-599 | Thyroid (1) | ESPE2014
, Mcclatchey Martin
, Kanzaria Shilpa
, Keane Morgan
, Banerjee Kausik
Background: Carbimazole is widely used in the treatment of Graves disease and is well tolerated but can produce adverse effects in 5% of cases. Urticaria, which can develop as a drug reaction to carbimazole responds to withdrawal of the drug and symptomatic management. Urticaria is also a rare manifestation of thyrotoxicosis and does not respond to treatment, but regresses rapidly with the control of underlying hyperthyroidism.Objective and hypothe...